The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AR nuclear localization and microtubule bundling as markers of docetaxel and cabazitaxel sensitivity in metastatic castration-resistant prostate cancer (mCRPC): Prospective biomarker analysis from TAXYNERGY.
 
Paraskevi Giannakakou
Employment - Novartis (I)
Stock and Other Ownership Interests - Novartis (I)
Research Funding - Sanofi
Patents, Royalties, Other Intellectual Property - International Patent Application DOCKET NO. 1676.083WO1 “Identifying Taxane Sensitivity in Prostate Cancer Patients” (Giannakakou, Plymate, co-inventors)
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; Dendreon; ESSA; Janssen Biotech; Medivation; Sanofi
Consulting or Advisory Role - Astellas Pharma; Dendreon; ESSA; Janssen Biotech; Medivation; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Giuseppe Galletti
No Relationships to Disclose
 
Daniel Worroll
No Relationships to Disclose
 
John Stewart
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Atef Zaher
Employment - Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sanofi
 
Ted P. Szatrowski
Employment - Sanofi
Stock and Other Ownership Interests - Roche; Sanofi
Consulting or Advisory Role - EMD Serono (I); Janssen (I); Lilly (I)
 
Wei Zhou
Employment - Sanofi
 
Karla V. Ballman
Consulting or Advisory Role - ARIAD; Hospira
Patents, Royalties, Other Intellectual Property - Immune enrichment signature for response to trastuzumab in HER2+ breast cancer (Inst); Prostate cancer signature patent (Inst)
 
Marie Vanhuyse
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Johnson & Johnson; Pfizer; Sanofi
Research Funding - sanofi (Inst)
 
Ada Gjyrezi
No Relationships to Disclose
 
Shinsuke Tasaki
No Relationships to Disclose
 
Yang Bai
No Relationships to Disclose
 
Luigi Portella
No Relationships to Disclose
 
Brian J. Kirby
Research Funding - Sanofi (Inst)
 
Guru Sonpavde
Honoraria - UpToDate
Consulting or Advisory Role - Agensys; Argos Therapeutics; AstraZeneca; Bayer; Eisai; Genentech; Janssen; Merck; Novartis; Pfizer; Sanofi
Speakers' Bureau - Clinical Care Options; National Cancer Care Network
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Onyx (Inst)
Other Relationship - Boehringer Ingelheim
 
Mario A. Eisenberger
Honoraria - Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Sanofi
Research Funding - Genentech; Sanofi; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Sanofi
 
David M. Nanus
Consulting or Advisory Role - Roche/Genentech
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Janssen Oncology; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Endocyte; Genentech; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Sanofi